NCT01098838View on ClinicalTrials.gov

Safety and Efficacy of LCL161 in Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions
Advanced Solid Tumors
Interventions
DRUG

LCL161

Trial Locations (3)

37203

Sarah Cannon Research Institute DeptofSarahCannonRes.Inst. (2), Nashville

27599-7295

UNC/ Lineberger Comprehensive Cancer Center Dept. of LinbergerCancerCtr(2), Chapel Hill

19111-2497

Fox Chase Cancer Center, Philadelphia

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY